Search Results

There are 5666 results for: content related to: Rejoinder for “Meta-analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling”

  1. Meta-analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 226–232, Debashis Ghosh, Jeremy M. G. Taylor and Daniel J. Sargent

    Article first published online : 13 JUN 2011, DOI: 10.1111/j.1541-0420.2011.01633.x

  2. Discussion by O'Quigley and Flandre

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 242–244, John O'Quigley and Philippe Flandre

    Article first published online : 13 JUN 2011, DOI: 10.1111/j.1541-0420.2011.01637.x

  3. Discussion Contribution to 091037PR4 (Ghosh, Taylor, and Sargent)

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 233–235, Geert Molenberghs

    Article first published online : 13 JUN 2011, DOI: 10.1111/j.1541-0420.2011.01634.x

  4. Discussions

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 239–241, Vance W. Berger, Grant Izmirlian and Diana Knoll

    Article first published online : 22 JUN 2011, DOI: 10.1111/j.1541-0420.2011.01636.x

  5. Discussion of the Paper of Ghosh, Taylor, and Sargent

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 236–238, Edward L. Korn

    Article first published online : 13 JUN 2011, DOI: 10.1111/j.1541-0420.2011.01635.x

  6. On Assessing Surrogacy in a Single Trial Setting Using a Semicompeting Risks Paradigm

    Biometrics

    Volume 65, Issue 2, June 2009, Pages: 521–529, Debashis Ghosh

    Article first published online : 27 AUG 2008, DOI: 10.1111/j.1541-0420.2008.01109.x

  7. Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 248–257, Stuart G. Baker, Daniel J. Sargent, Marc Buyse and Tomasz Burzykowski

    Article first published online : 13 AUG 2011, DOI: 10.1111/j.1541-0420.2011.01646.x

  8. Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation

    Pharmaceutical Statistics

    Volume 5, Issue 3, July/September 2006, Pages: 173–186, Tomasz Burzykowski and Marc Buyse

    Article first published online : 10 MAY 2006, DOI: 10.1002/pst.207

  9. Statistical evaluation of biomarkers as surrogate endpoints: a literature review

    Statistics in Medicine

    Volume 25, Issue 2, 30 January 2006, Pages: 183–203, Christopher J. Weir and Rosalind J. Walley

    Article first published online : 26 OCT 2005, DOI: 10.1002/sim.2319

  10. Semiparametric Inference for Surrogate Endpoints with Bivariate Censored Data

    Biometrics

    Volume 64, Issue 1, March 2008, Pages: 149–156, Debashis Ghosh

    Article first published online : 25 JUL 2007, DOI: 10.1111/j.1541-0420.2007.00834.x

  11. On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints

    Biometrics

    Ariel Alonso, Wim Van der Elst, Geert Molenberghs, Marc Buyse and Tomasz Burzykowski

    Article first published online : 1 OCT 2014, DOI: 10.1111/biom.12245

  12. Potential surrogate endpoints in cancer research – some considerations and examples

    Pharmaceutical Statistics

    Volume 10, Issue 1, January/February 2011, Pages: 34–39, S. W. Duffy and F. P. Treasure

    Article first published online : 22 DEC 2009, DOI: 10.1002/pst.406

  13. Surrogate Marker Evaluation from an Information Theory Perspective

    Biometrics

    Volume 63, Issue 1, March 2007, Pages: 180–186, Ariel Alonso and Geert Molenberghs

    Article first published online : 24 AUG 2006, DOI: 10.1111/j.1541-0420.2006.00634.x

  14. Comparing Biomarkers as Principal Surrogate Endpoints

    Biometrics

    Volume 67, Issue 4, December 2011, Pages: 1442–1451, Ying Huang and Peter B. Gilbert

    Article first published online : 22 APR 2011, DOI: 10.1111/j.1541-0420.2011.01603.x

  15. Bayesian Adaptive Trial Design for a Newly Validated Surrogate Endpoint

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 258–267, Lindsay A. Renfro, Bradley P. Carlin and Daniel J. Sargent

    Article first published online : 12 AUG 2011, DOI: 10.1111/j.1541-0420.2011.01647.x

  16. Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trials

    Statistics in Medicine

    Volume 31, Issue 8, 13 April 2012, Pages: 743–761, Lindsay A. Renfro, Qian Shi, Daniel J. Sargent and Bradley P. Carlin

    Article first published online : 9 DEC 2011, DOI: 10.1002/sim.4416

  17. Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach

    Biometrics

    Volume 60, Issue 4, December 2004, Pages: 845–853, Ariel Alonso, Helena Geys, Geert Molenberghs, Michael G. Kenward and Tony Vangeneugden

    Article first published online : 6 DEC 2004, DOI: 10.1111/j.0006-341X.2004.00239.x

  18. Related Causal Frameworks for Surrogate Outcomes

    Biometrics

    Volume 65, Issue 2, June 2009, Pages: 530–538, Marshall M. Joffe and Tom Greene

    Article first published online : 27 AUG 2008, DOI: 10.1111/j.1541-0420.2008.01106.x

  19. The authors replied as follows:

    Biometrics

    Volume 63, Issue 3, September 2007, Pages: 960–962, A. Alonso, G. Molenberghs, T. Burzykowski, D. Renard, H. Geys, Z. Shkedy, F. Tibaldi, J. Cortinas Abrahantes and M. Buyse

    Article first published online : 31 AUG 2007, DOI: 10.1111/j.1541-0420.2007.00852_2.x

  20. A statistician's perspective on biomarkers in drug development

    Pharmaceutical Statistics

    Volume 10, Issue 6, November/December 2011, Pages: 494–507, Martin Jenkins, Aiden Flynn, Trevor Smart, Chris Harbron, Tony Sabin, Jayantha Ratnayake, Paul Delmar, Athula Herath, Philip Jarvis, James Matcham and on behalf of the PSI Biomarker Special Interest Group

    Article first published online : 8 DEC 2011, DOI: 10.1002/pst.532